The EU project InnovaBone involves a large EU wide consortium working to produce a novel scaffold containing biogel to promote bone repair. The goal is to ensure strong, healthy bone regeneration reducing the pain and suffering of patients. Cambridge is involved in the biological characterisation of the materials using primary osteoblasts and monocytes.
The input of the Cambridge Musculoskeletal Sciences Network is essential not only in sourcing the primary cells but also in the expertise there. The Cambridge Centre for Medical materials works closely with researchers in the Division of Trauma and Orthopaedic Surgery meaning that simple tweaks to experiments are easily made and so much more detail is obtained from the experiments than would be gathered without this input.